Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells

Immunity

Volumn 12, Issue 1, 2000, Pages 107-117

  Morel, Sandra ^a   Lévy, Frédéric ^b   Burlet Schiltz, Odile ^c   Brasseur, Francis ^a   Probst Kepper, Michaël ^a   Peitrequin, Anne Lise ^b   Monsarrat, Bernard ^c   Van Velthoven, Robert ^d   Cerottini, Jean Charles ^b   Boon, Thierry ^a   Gairin, Jean Edouard ^c   Van den Eynde, Benoît J ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Switzerland)

^c CNRS   (France)

^d JULES BORDET INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; MELANOMA ANTIGEN; PROTEASOME;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; VACCINATION;

EID: 0033980648     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80163-6     Document Type: Article

References (50)

1. Amsen, D., and Kruisbeek, A.M. (1998). Thymocyte selection: not by TCR alone. Immunol. Rev. 165, 209-229.
2. Ardavìn, C. (1997). Thymic dendritic cells. Immunol. Today 18, 350-361.
3. Ayyoub, M., Monsarrat, B., Mazarguil, H., and Gairin, J.E. (1998). Analysis of the degradation mechanisms of MHC class I-presented tumor antigenic peptides by high performance liquid chromatography/electrospray ionization mass spectrometry: application to the design of peptidase-resistant analogs. Rapid Commun. Mass Spectrom. 12, 557-564.
4. Beninga, J., Rock, K.L., and Goldberg, A.L. (1998). Interferon-γ can stimulate post-proteasomal trimming of the N terminus of an antigenic peptide by inducing leucine aminopeptidase. J. Biol. Chem. 273, 18734-18742.
5. Boon, T., Van Snick, J., Van Pel, A., Uyttenhove, C., and Marchand, M. (1980). Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis. J. Exp. Med. 152, 1184-1193.
6. Brasseur, F., Rimoldi, D., Liénard, D., Lethé, B., Carrel, S., Arienti, F., Suter, L., Vanwijck, R., Bourlond, A., Humblet, Y., et al. (1995). Expression of MAGE genes in primary and metastatic cutaneous melanoma. Int. J. Cancer 63, 375-380.
7. Cerundolo, V., Benham, A., Braud, V., Mukherjee, S., Gould, K., Macino, B., Neefjes, J., and Townsend, A. (1997). The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells. Eur. J. Immunol. 27, 336-341.
8. Cerundolo, V., Kelly, A., Elliott, T., Trowsdale, J., and Townsend, A. (1995). Genes encoded in the major histocompatibility complex affecting the generation of peptides for TAP transport. Eur. J. Immunol. 25, 554-562.
9. De Plaen, E., Lurquin, C., Lethé, B., van der Bruggen, P., Brichard, V., Renauld, J.-C., Coulie, P., Van Pel, A., and Boon, T. (1997). Identification of genes coding for tumor antigens recognized by cytolytic T lymphocytes. Methods 12, 125-142.
10. Dick, T.P., Nussbaum, A.K., Deeg, M., Heinemeyer, W., Groll, M., Schirle, M., Keilhoz, W., Stevanovic, S., Wolf, D.H., Huber, R., et al. (1998). Contribution of proteasomal β-subunits to the cleavage of peptide substrates analyzed with yeast mutants. J. Biol. Chem. 273, 25637-25646.
11. Espevik, T., and Nissen-Meyer, J. (1986). A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95, 99-105.
12. Fehling, H.J., Swat, W., Laplace, C., Kühn, R., Rajewsky, K., Müller, U., and von Boehmer, H. (1994). MHC class I expression in mice lacking the proteasome subunit LMP-7. Science 265, 1234-1237.
13. Freedman, A.S., Freeman, G.J., Rhynhart, K., and Nadler, L.M. (1991). Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes. A potential mechanism for amplification of T cell activation through the CD28 pathway. Cell. Immunol. 137, 429-437.
14. Frisan, T., Levitsky, V., Polack, A., and Masucci, M.G. (1998). Phenotype-dependent differences in proteasome subunit composition and cleavage specificity in B cell lines. J. Immunol. 160, 3281-3289.
15. Gaczynska, M., Rock, K.L., and Goldberg, A.L. (1993). γ-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 365, 264-267.
16. Gaczynska, M., Goldberg, A.L., Tanaka, K., Hendil, K.B., and Rock, K.L. (1996). Proteasome subunits X and Y alter peptidase activities in opposite ways to the interferon-γ-induced subunits LMP2 and LMP7. J. Biol. Chem. 271, 17275-17280.
17. Gaugler, B., Van den Eynde, B., van der Bruggen, P., Romero, P., Gaforio, J.J., De Plaen, E., Lethé, B., Brasseur, F., and Boon, T. (1994). Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med. 179, 921-930.
18. Gaugler, B., Brouwenstijn, N., Vantomme, V., Szikora, J.-P., Van der Spek, C.W., Patard, J.-J., Boon, T., Schrier, P., and Van den Eynde, B.J. (1996). A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal carcinoma. Immunogenetics 44, 323-330.
19. Gazdar, A.F., and Oie, H.K. (1986). Re: Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium. Cancer Res. 46, 6011-6012.
20. Glynne, R., Powis, S.H., Beck, S., Kelly, A., Kerr, L.-A., and Trowsdale, J. (1991). A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHC. Nature 353, 357-360.
21. Groll, M., Heinemeyer, W., Jäger, S., Ullrich, T., Bochtler, M., Wolf, D.H., and Huber, R. (1999). The catalytic sites of 20S proteasomes and their role in subunit maturation: a mutational and crystallographic study. Proc. Natl. Acad. Sci. USA 96, 10976-10983.
22. Guéguen, M., Patard, J.-J., Gaugler, B., Brasseur, F., Renauld, J.-C., Van Cangh, P.J., Boon, T., and Van den Eynde, B. (1998). An antigen recognized by autologous CTL on a human bladder carcinoma. J. Immunol. 160, 6188-6194.
23. Hérin, M., Lemoine, C., Weynants, P., Vessière, F., Van Pel, A., Knuth, A., Devos, R., and Boon, T. (1987). Production of stable cytolytic T-cell clones directed against autologous human melanoma. Int. J. Cancer 39, 390-396.
24. Ikeda, H., Lethé, B., Lehmann, F., Van Baren, N., Baurain, J.-F., De Smet, C., Chambost, H., Vitale, M., Moretta, A., Boon, T., and Coulie, P.G. (1997). Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity 6, 199-208.
25. Jäger, E., Ringhoffer, M., Dienes, H.P., Arand, M., Karbach, J., Jager, D., Ilsemann, C., Hagedorn, M., Oesch, F., and Knuth, A. (1996a). Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo. Int. J. Cancer 67, 54-62.
26. + cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo. Int. J. Cancer 66, 470-476.
27. Jonuleit, H., Kuhn, U., Muller, G., Steinbrink, K., Paragnik, L., Schmitt, E., Knop, J., and Enk, A.H. (1997). Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 27, 3135-3142.
28. Kawakami, Y., Eliyahu, S., Sakaguchi, K., Robbins, P.F., Rivoltini, L., Yannelli, J.R., Appella, E., and Rosenberg, S.A. (1994). Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med. 180, 347-352.
29. Kawakami, Y., Eliyahu, S., Jennings, C., Sakaguchi, K., Kang, X., Southwood, S., Robbins, P.F., Sette, A., Appella, E., and Rosenberg, S.A. (1995). Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J. Immunol. 154, 3961-3968.
30. Kelly, A., Powis, S.H., Glynne, R., Radley, E., Beck, S., and Trowsdale, J. (1991). Second proteasome-related gene in the human MHC class II region. Nature 353, 667-668.
31. Kowalzick, L, Weyer, U., Lange, P., and Breitbart, E.W. (1990). Systemic therapy of advanced metastatic malignant melanoma with a combination of fibroblast interferon-beta and recombinant interferon-gamma. Dermatologica 181, 298-303.
32. Martinez, C.K., and Monaco, J.J. (1991). Homology of proteasome subunits to a major histocompatibility complex-linked LMP gene. Nature 353, 664-667.
33. Meyskens, F.L., Kopecky, K., Samson, M., Hersh, E., Macdonald, J., Jaffe, H., Crowley, J., and Coltman, C. (1990). Recombinant human Interferon γ: adverse effects in high-risk stage I and II cutaneous malignant melanoma. J. Natl. Cancer Inst. 82, 1071.
34. Nestle, F.O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G., and Schadendorf, D. (1998). Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nat. Med. 4, 328-332.
35. Ortiz-Navarrete, V., Seelig, A., Gernold, M., Frentzel, S., Kloetzel, P.M., and Hämmerling, G.J. (1991). Subunit of the '20S' proteasome (multicatalytic proteinase) encoded by the major histocompatibility complex. Nature 353, 662-664.
36. Rock, K.L., and Goldberg, A.L. (1999). Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu. Rev. Immunol. 17, 739-779.
37. Rock, K.L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., and Goldberg, A.L. (1994). Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78, 761-771.
38. Romani, N., Gruner, S., Brang, D., Kämpgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G., Fritsch, P.O., Steinman, R.M. and Schuler, G. (1994). Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180, 83-93.
39. Romero, P., Rod Dunbar, P., Valmori, D., Pittet, M., Ogg, G.S., Rimoldi, D., Chen, J.L., Lienard, D., Cerottini, J.C., and Cerundolo, V. (1998). Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J. Exp. Med. 188, 1641-1650.
40. Rosenberg, S.A., Yang, J.C., Schwartzentruber, D.J., Hwu, P., Marincola, F.M., Topalian, S.L., Restifo, N.P., Dudley, M.E., Schwarz, S.L., Spiess, P.J., et al. (1998). Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat. Med. 4, 321-327.
41. Sallusto, F., and Lanzavecchia, A. (1994). Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179, 1109-1118.
42. Stohwasser, R., Standera, S., Peters, I., Kloetzel, P.-M., and Groettrup, M. (1997). Molecular cloning of the mouse proteasome subunits MC14 and MECL-1: reciprocally regulated tissue expression of interferon-γ-modulated proteasome subunits. Eur. J. Immunol. 27, 1182-1187.
43. Stoltze, L., Dick, T.P., Deeg, M., Pömmerl, B., Rammensee, H.-G., and Schild, H. (1998). Generation of the vesicular stomatitis virus nucleoprotein cytotoxic T lymphocyte epitope requires proteasome-dependent and -independent proteolytic activities. Eur. J. Immunol. 28, 4029-4036.
44. Tanaka, K., and Kasahara, M. (1998). The MHC class I ligand-generating system: roles of immunoproteasomes and the interferon-γ-inducible proteasome activator PA28. Immunol. Rev. 163, 161-176.
45. Traversari, C., van der Bruggen, P., Luescher, I.F., Lurquin, C., Chomez, P., Van Pel, A., De Plaen, E., Amar-Costesec, A., and Boon, T. (1992a). A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J. Exp. Med. 176, 1453-1457.
46. Traversari, C., van der Bruggen, P., Van den Eynde, B., Hainaut, P., Lemoine, C., Ohta, N., Old, L., and Boon, T. (1992b). Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics 35, 145-152.
47. Valmori, D., Gileadi, U., Servis, C., Dunbar, P.R., Cerottini, J.-C., Romero, P., Cerundolo, V., and Lévy, F.(1999). Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3. J. Exp. Med. 189, 895-906.
48. Van Kaer, L., Ashton-Rickardt, P.G., Eichelberger, M., Gaczynska, M., Nagashima, K., Rock, K.L., Goldberg, A.L., Doherty, P.C., and Tonegawa, S. (1994). Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity 1, 533-541.
49. Yoshida, A., Koide, Y., Uchijima, M., and Yoshida, T.O. (1994). IFN-γ induces IL-12 mRNA expression by a murine macrophage cell line, J774. Biochem. Biophys. Res. Commun. 198, 857-861.
50. Zanelli, E., Zhou, P., Cao, H., Smart, M.K., and David, C.S. (1993). Genomic organization and tissue expression of the mouse proteasome gene Lmp-7. Immunogenetics 38, 400-407.